Mutagenesis, tumorigenicity, and apoptosis: Are the mitochondria involved?

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 398, Issue 1-2, 1998, Pages 19-26

  Cavalli, Luciane R ^a,b   Liang, Bertrand C ^a,c  

^a UNIVERSITY OF COLORADO   (United States)

^b FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^c UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

Apoptosis; Mitochondria; Mitochondrial DNA; Tumorigenicity

Indexed keywords

CARCINOGEN; MITOCHONDRIAL DNA;

APOPTOSIS; CANCER CELL; CARCINOGENESIS; CARCINOGENICITY; FUNCTIONAL ASSESSMENT; GLYCOLYSIS; HUMAN; IN VITRO STUDY; MITOCHONDRION; MUTAGENESIS; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; REVIEW;

EID: 0032574319     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(97)00223-6     Document Type: Article

References (76)

1. Warburg O., Wind F., Negelein E. Uber den Stoffwechsel von Tumoren in Korper. Klin. Woch. 5:1926;829-832.
2. Warburg O. On the origin of cancer cells. Science. 123:1956;309-314.
3. Burk D. A colloquial consideration of the pasteur and neo-pasteur effects. Cold Springs Harbor Symposium. Quant. Biol. 7:1939;420-455.
4. Weinhouse S. Oxidative metabolism of neoplastic tissue. Adv. Cancer Res. 3:1955;269-329.
5. Weinhouse S. On respiratory impairment in cancer cells. Science. 124:1956;267-269.
6. Burk D., Schade A.L. On respiratory impairment in cancer cells. Science. 124:1956;270-272.
7. Hruban Z., Mochisuki Y., Morris H.P., Slessers A.J. Ultrastructure of Morris renal tumors. J. Natl. Canc. Inst. 50:1973;1487-1495.
8. White M.T., Ayra D.V., Tewari K.K. Biochemical properties of neoplastic cell mitochondria. J. Natl. Cancer Inst. 53:1974;553-559.
9. Baggeto L.G. Role of mitochondria in carcinogenesis. Eur. J. Cancer. 29A:1993;156-159.
10. Clayton D.A., Vinograd J. Circular dimers and catenate of mitochondrial DNA in human leukemia leucocytes. Nature. 216:1967;652-653.
11. Firskin F.C., Clark-Wakler G.D. Abnormal mitochondrial DNA in acute leukemia and lymphoma. Br. J. Hematol. 43:1979;201-206.
12. Clayton D.A., Smith C.A. Complex mitochondrial DNA. Int. Rev. Exp. Pathol. 14:1975;1-67.
13. Eguchi M., Iwama Y., Ochiai F., Ishikawa K., Sakakibara H., Sakamake H., Furukawa T. Giant mitochondria in acute lymphocytic leukemia. Exp. Mol. Pathol. 47:1987;69-75.
14. Welter C., Kovacs G., Seits G., Blin N. Alteration of mitochondrial DNA in human oncocytomas. Genes Chr. Cancer. 1:1989;79-82.
15. Gianni A.M., Dalla-Favera R., Polli E. Restriction enzyme analysis of human leukemic mitochondrial DNA. Leukemia Res. 4:1980;155-160.
16. Taira M., Yoshida E., Kobayashi K., Koike K. Tumor associated mutations of rat mitochondrial RNA genes. Nucleic Acids Res. 11:1983;1635-1643.
17. Yamamoto H., Tanaka M., Katayama M., Obayashi T., Nimura Y., Takayuki O. Significant existence of deleted mitochondrial DNA in cirrhotic liver surrounding hepatic tumour. Biochem. Biophys. Res. Commun. 182:1992;913-920.
18. Johanssen J., Harris H. The analysis of malignancy by cell fusion. VIII. Evidence for the intervention of an extra chromosomal element J. Cell Sci. 24:1977;255-263.
19. Howell A.N., Sager R. Tumorigenicity and its suppression in cybrids of mouse and Chinese hamster cell lines. Proc. Natl. Acad. Sci. USA. 75:1978;2358-2362.
20. Howell A.N., Sager R. Genetic analysis of tumorigenesis. VIII: Suppression of SV 40 transformation in cell hybrids and cytoplasmic transferrants Cytogenet. Cell Genet. 31:1981;214-227.
21. Giguer L., Morais R. On suppression of tumorigenicity in hybrid and cybrid mouse cells. Somat. Cell Genet. 7(4):1981;457-471.
22. Israel B.A., Schaeffer W.I. Cytoplasmic hybrids (cybrids) and reconstructed cells between normal and tumorigenic rat liver cells: suppression of the tumorigenic phenotype. In vitro. 18:1982;284a.
23. Israel B.A., Schaeffer W.I. Cytoplasmic suppression of malignancy. In Vitro Cell Dev. Biol. 23:1987;627-632.
24. Corral M.G., Baffet A., Kitzis B., Paris L., Tichonicky J., Kruh C., Guguen-Guillouzo C., Defer N. DNA sequences homologous to mitochondrial genes in nuclei from normal rat tissues and from rat hepatoma cells. Biochem. Biophys. Res. Commun. 162:1989;258-264.
25. Tourmente S., Savre-Train I., Berthier F. Expression of 6 mitochondrial genes during Drosophila oogenesis: analysis by in situ hybridization. Cell Diff. Dev. 37:1990;137-149.
26. Shay J.W., Baba T., Zhan Q., Kamimura N., Cuthbert J.A. HeLa TG cells have mitochondrial DNA inserted into the c-myc oncogene. Oncogene. 6:1991;1869-1874.
27. Zullo S., Sieu L.C., Slightom J.L., Hadler H.I., Eisenstadt J.M. Mitochondrial D loop sequences are integrated in the rat nuclear genome. J. Mol. Biol. 221:1991;1223-1235.
28. Ossorio P.N., Sibley L.D., Boothroyd J.C. Mitochondrial-like DNA sequences flanked by direct and inverted repeats in the nuclear genome of Toxoplasma gondii. J. Mol. Biol. 222:1991;525-536.
29. Gellissen G., Michaelis G. Gene transfer: mitochondria to nucleus. Ann. NY Acad. Sci. 503:1987;391-401.
30. Farelly F., Buttow R. Rearranged mitochondrial genes in the yeast nuclear genome. Nature. 301:1983;296-301.
31. Thorsness P.E., Fox T.D. Escape of DNA from mitochondria to the nucleus in Saccharomyces cerevisiae. Nature. 346:1990;376-379.
32. Kristensen T., Prydz H. The presence of intact mitochondrial DNA in HeLa cell nuclei. Nucleic Acids Res. 14:1986;2597-2609.
33. Shay J.W., Werbin H. New evidence for insertion of mitochondrial DNA sequences into the human genome: significance for cancer and aging. Mutation Res. 275:1992;227-235.
34. Corral M., Paris B., Baffet G., Tichonicky L., Guguen-Guillouzo C., Kruh J., Defer N. Increased level of the mitochondrial ND5 transcript in chemically induced rat hepatomas. Exp. Cell Res. 184:1989;158-166.
35. Liang B.C. Evidence for association of mitochondrial DNA sequence amplification and nuclear localization in human low-grade gliomas. Mutation Res. 354:1996;27-33.
36. Nugent J.M., Palmer J.D. RNA-mediated transfer of the gene coxII from the mitochondrion to the nucleus during flowering plant evolution. Cell. 66:1991;473-481.
37. Thorsness P.E., Fox T.D. Nuclear mutations in Saccharomyces cerevisiae that affect escape of DNA from mitochondria to the nucleus. Genetics. 134:1993;21-28.
38. Campbell C.L., Tanaka N., White K.W., E Thorsness P. Mitochondrial morphological and functional defects in yeast caused by yme1 are suppressed by mutation of a 26S protease subunit homologue. Mol. Biol. Cell. 5:1994;899-905.
39. Chiang H.L., Schikman R. Regulated import and degradation of a cytosolic protein in the yeast vacuole. Nature. 350:1991;313-318.
40. Baba M., Takeshige K., Baba N., Oshumi Y. Ultrastructural analysis of the autophagic process in yeast: Detection of autophagosomes and their characterization. J. Cell Biol. 124:1994;903-913.
41. Liang S., Alksne L., Warner J.R., Lacroute F. RNA 12+, a gene of Saccharomyces cerevisiae involved in pre-rRNA maturation. Characterization of a temperature-sensitive mutant, cloning and sequencing of the gene. Mol. Gen. Genet. 232:1992;304-312.
42. Burgess S.M., Delannoy M., Jensen R.E. MMM1 encodes a mitochondrial outer membrane protein essential for establishing and maintaining the structure of yeast mitochondria. J. Cell Biol. 126:1994;1375-1391.
43. Hokt I.J., Harding A.E., Petty R.K.H., Morgan-Hughes J.A. Deletions of mitochondrial DNA in patients with mitochondrial myopathies. Nature. 331:1988;717-719.
44. Shoffner J.M., Wallace D.C. Mitochondrial genetics: principles and practices. Am. J. Hum. Genet. 51:1992;1179-1186.
45. Welter C., Kovacs G., Seitz G., Blin N. Alterations of mitochondrial DNA in human oncocytomas. Genes Chr. Cancer. 1:1989;79-82.
46. Wilkie D., Evans I. Mitochondrial and the yeast cell surface: implication for carcinogenesis. Trends Biochem. Sci. 7:1980;147-151.
47. Wilkie D., Evans I., Egilsson V., Diala E., Collier D. Mitochondria, cell surface and carcinogenesis. Int. Rev. Cytol. 15:1983;157-189.
48. King M.P., Attardi G. Human cells lacking mitochondrial DNA: repopulation with exogenous mitochondria by complementation. Science. 246:1989;500-503.
49. Nass M.M.K. Differential effects of ethidium bromide on mitochondrial and nuclear DNA synthesis in vitro in cultured mammalian cells. Exp. Cell Res. 72:1972;211-222.
50. Desjardins P., Frost E., Moraes R. Ethidium bromide-induced loss of mitochondrial DNA from primary chicken embryo fibroblasts. Mol. Cell. Biol. 5:1985;1163-1169.
51. Morais R., Desjardins P., Turmel C., Zinkewich-Peotti K. Development and characterization of continuous avian cell lines depleted of mitochondrial DNA. In Vitro Cell Dev. Biol. 24:1988;649-658.
52. Newbold R.F., Overell R.W., Connell J.R. Jr. Induction of immortality is an early event in malignant transformation of mammalian cells by carcinogens. Nature. 299:1982;633-635.
53. Zinkewich-Peotti K., Parent M., Morais R. Mitochondrial DNA modulation of the anchorage-independent phenotype of transformed avian cells. Cancer Res. 50:1990;6675-6682.
54. Zinkewich-Peotti K., Parent M., Morais R. On the tumorigenicity of mitochondrial depleted avian cells. Cancer Lett. 59:1991;119-124.
55. Morais R., Zinkewich-Peotti M., Parent M., Wang H., Babai F., Zollinger M. Tumor-forming ability in athymic nude mice of human cell lines devoid of mitochondrial DNA. Cancer Res. 54:1994;3889-3896.
56. Nikiforov M.A., Hagen K., Ossovskaya V.S., Connor T.M.F., Lowe S.W., Deichman I., Gudkov A.V. p53 modulation of anchorage independent growth and experimental metastasis. Oncogene. 13:1996;1709-1719.
57. Sierra A., Lloveras B., Castellsague X., Moreno L., Garcia-Ramirez M., Fabra A. Bcl-2 expression is associated with lymph node metastasis in human ductal breast carcinoma. Int. J. Cancer. 60:1995;54-60.
58. Jacobson M.D., Burne J.F., Raff M.C. Programmed cell death and bcl-2 protection in the absence of a nucleus. EMBO J. 13:1994;1899-1910.
59. Schulze-Osthoff K., Walczac H., Droge W., Krammer Cell nucleus and DNA fragmentation are not required for apoptosis. J. Cell. Biol. 127:1994;15-20.
60. Zamzani N., Marchetti P., Castedo M., Zanin C., Vayssiere J.-L., Peti P.X., Kroemer G. Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo. J. Exp. Med. 181:1995;1661-1672.
61. Petit P.X., LeCouer H., Zorn E., Dauget C., Mignotte B., Gougeon M.L. Alterations of mitochondrial structure and function are early events of dexamethasone-induced thymocyte apoptosis. J. Cell Biol. 130:1995;156-167.
62. Cossarizza A., Franceschi C., Monti D., Salvioli S., Bellesia E., Rivabene R., Biondo L., Rainaldi G., Tinari A., Malorni W. Protective effect of N-acetylcysteine in tumor necrosis factor-α-induced apoptosis in U937 cells: the role of mitochondria. Exp. Cell Res. 220:1995;232-240.
63. Castedo M., Macho A., Zamzani N., Hirsch T., Marchetti P., Uriel J., Kroemer G. Mitochondrial perturbations define lymphocytes undergoing apoptotic depletion in vivo. Eur. J. Immunol. 25:1995;3277-3284.
64. Kroemer G., Petit P.X., Zamzani N., Vayssiere J.L., Mignotte B. The biochemistry of apoptosis. FASEB J. 9:1995;1277-1287.
65. Marchetti P., Susin S.A., Decaudin D., Gamen S., Castedo M., Hirsch T., Zamzani N., Naval J., Senik A., Kroemer G. Apoptosis associated derangement of mitochondrial function in cells lacking mitochondrial DNA. Cancer Res. 56:1996;2033-2038.
66. Marchetti P., Castedo M., Susin S.A., Zamzani N., Hirsch T., Macho A., Haeffner A., Hirsch F., Geuskens M., Kroemer G. Mitochondrial permeability transition is a central coordinating event of apoptosis. J. Exp. Med. 184:1996;1155-1160.
67. L antagonize the mitochondrial dysfunction preceding nuclear apoptosis induced by chemotherapeutic agents. Cancer Res. 57:1997;62-67.
68. Zamzani N., Marchetti P., Castedo M., Hirsch T., Susin S.A., Masse B., Kroemer G. Inhibitors of permeability transition interfere with the disruption of the mitochondrial transmembrane potential during apoptosis. FEBS Lett. 384:1996;53-57.
69. Newmeyer D.D., Farschon D.M., Reed J.C. Cell-free apoptosis in Xenopus egg extracts: inhibition by Bcl-2 and requirement for an organelle fraction enriched in mitochondria. Cell. 79:1994;353-364.
70. Martin S.J., Newmeyer D.D., Mathisa S., Farschon D.M., Wang H.G., Reed J.C., Kolesnick R.N., Green D.R. Cell-free reconstitution of Fas-, UV radiation-, and ceramide-induced apoptosis. EMBO J. 14:1995;5191-5200.
71. Yang J., Liu X., Bhalla K., Kim C.N., Ibrado A.M., Cai J., Peng T.-I., Jones D.P., Wang X. Prevention of apoptosis by bcl-2: release of cytochrome c from mitochondria blocked. Science. 275:1997;1129-1132.
72. Kluck R.M., Bossy-Wetzel E., Green D.R., Newmeyer D.D. The release of cytochrome c from mitochondria: a primary site for bcl-2 regulation of apoptosis. Science. 275:1997;1132-1136.
73. Heerdt B.G., Houston M.A., Augenlicht L.H. Short-chain fatty acid-initiated cell cycle arrest and apoptosis of colonic epithelial cells is linked to mitochondrial function. Cell Growth Diff. 8:1997;523-532.
74. Chiou S.K., Rao L., White E. Bcl-2 blocks p53-dependent apoptosis. Mol. Cell Biol. 14:1994;2556-2563.
75. Miyashita T., Harigai M., Hanada M., Reed J.C. Identification of a p53-dependent negative response element in the bcl-2 gene. Cancer Res. 54:1994;3131-3135.
76. L forms an ion channel in synthetic lipid membranes. Nature. 385:1997;353-357.